相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Present, Emerging and Possible Future Biomarkers in Castration Resistant Prostate Cancer (CRPC)
Martin Boegemann et al.
CURRENT CANCER DRUG TARGETS (2015)
Recent trends in incidence of five common cancers in 26 European countries since 1988: Analysis of the European Cancer Observatory
Melina Arnold et al.
EUROPEAN JOURNAL OF CANCER (2015)
Significance of Apoptotic and Non-apoptotic Disseminated Tumor Cells in the Bone Marrow of Patients With Clinically Localized Prostate Cancer
Tilman Todenhoefer et al.
PROSTATE (2015)
Predicting treatment response in castration-resistant prostate cancer: could androgen receptor variant-7 hold the key?
Emmanuel S. Antonarakis
EXPERT REVIEW OF ANTICANCER THERAPY (2015)
EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer
Axel Heidenreich et al.
EUROPEAN UROLOGY (2014)
Adjuvant Radiotherapy Versus Wait-and-See After Radical Prostatectomy: 10-year Follow-up of the ARO 96-02/AUO AP 09/95 Trial
Thomas Wiegel et al.
EUROPEAN UROLOGY (2014)
A biomarker based detection and characterization of carcinomas exploiting two fundamental biophysical mechanisms in mammalian cells
Martin Grimm et al.
BMC CANCER (2013)
EDIM-TKTL1 blood test: a noninvasive method to detect upregulated glucose metabolism in patients with malignancies
Oliver Feyen et al.
FUTURE ONCOLOGY (2012)
Current Challenges in Development of Differentially Expressed and Prognostic Prostate Cancer Biomarkers
Steven M. Lucas et al.
PROSTATE CANCER (2012)
Tumor markers in prostate cancer I: Blood-based markers
Shahrokh F. Shariat et al.
ACTA ONCOLOGICA (2011)
Expression of Transketolase like gene 1 (TKTL1) predicts disease-free survival in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy
Juliana Schwaab et al.
BMC CANCER (2011)
Predictive Value of the Differential Expression of the Urokinase Plasminogen Activation Axis in Radical Prostatectomy Patients
Amit Gupta et al.
EUROPEAN UROLOGY (2009)
Circulating PSA-containing macrophages as a possible target for the detection of prostate cancer
Math P. G. Leers et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
Detecting prostate cancer by intracellular macrophage prostate-specific antigen (PSA):: a more specific and sensitive marker than conventional serum total PSA
R. Herwig et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2008)
Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis
Shahrokh F. Shariat et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Association of pre- and postoperative plasma levels of transforming growth factor β1 and interleukin 6 and its soluble receptor with prostate cancer progression
SF Shariat et al.
CLINICAL CANCER RESEARCH (2004)
Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter
IM Thompson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Markers and meaning of primary treatment failure
PW Swindle et al.
UROLOGIC CLINICS OF NORTH AMERICA (2003)
Serum human glandular kallikrein-2 protease levels predict the presence of prostate cancer among men with elevated prostate-specific antigen
RK Nam et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
